Carisma Therapeutics Presents Promising New Preclinical Knowledge on Engineered Macrophages for the Remedy of Liver Fibrosis at AASLD The Liver Assembly ® 2024 By Investing.com
New preclinical outcomes help the anti-fibrotic potential of engineered macrophages in a…
